Potentials of Bombax ceiba thorn extract

Excerpt:


J Pharm Pharmacogn Res 5(1): 40-54, 2017. Original Article | Artículo Original Pharmacognostic and pharmacological studies of Bombax ceiba thorn extract [Estudios farmacognóstico y farmacológico del extracto de espina de Bombax ceiba] Manish A. Kamble, Debarshi Kar Mahapatra*, Disha M. Dhabarde, Ashwini R. Ingole Department of Pharmacognosy, Kamla Nehru College of Pharmacy, Nagpur – 441108, Maharashtra, India. *E-mail: dkmbsp@gmail.com … Continue reading Potentials of Bombax ceiba thorn extract

J Pharm Pharmacogn Res 5(1): 40-54, 2017.

Original Article | Artículo Original

Pharmacognostic and pharmacological studies of Bombax ceiba thorn extract

[Estudios farmacognóstico y farmacológico del extracto de espina de Bombax ceiba]

Manish A. Kamble, Debarshi Kar Mahapatra*, Disha M. Dhabarde, Ashwini R. Ingole

Department of Pharmacognosy, Kamla Nehru College of Pharmacy, Nagpur – 441108, Maharashtra, India.

*E-mail: dkmbsp@gmail.com

Abstract

Context: Bombax ceiba is a large deciduous tree found in tropical and sub-tropical regions of Asia, Africa, and Australia. Traditional systems of medicine such as Ayurveda, Siddha and Unani have been highlighted the use of B. ceiba parts (bark, leaves, and flower) for the treatment of numerous ailments like algesia, hepatotoxicity, hypertension, HIV infections, fever, dysentery, inflammation, catarrhal affection, ulcer, acne, gynecological disorders, piles and urinary infections. However, no scientific pharmacognostic, phytochemical and pharmacological study has been reported for B. ceiba thorn.

Aims: To study the pharmacognostic and pharmacological potentials of B. ceiba thorn extract.

Methods: The physicochemical properties were determined using pharmacopoeial tests. The phytochemical screening was carried out using standard protocols. The in vitro anti-inflammatory activity was performed by human red blood cells stabilization method, in vitro anthelmintic activity by Pheretima posthuma method, in vitro antioxidant activity by DPPH scavenging method, and anti-microbial studies by agar streak dilution method against bacteria E. coli, B. subtilis, K. pneumonia, and fungi C. albicans and A. niger.

Results: The hydroalcoholic thorn extract of Bombax ceiba (TEBC) showed significant anti-inflammatory (46.9% stabilization), anthelmintic (death at 59.22 min), in vitro anti-oxidant (41.62% inhibition), and anti-microbial activities (B. subtilis > E. coli > K. pneumonia; A. niger > C. albicans).

Conclusions: The study revealed the physicochemical, photochemical and pharmacognostic features of thorn of the B. ceiba. The study also revealed the possession of different pharmacological potentials of extract.

Keywords: anthelmintic; anti-inflammatory; antimicrobial; Bombax ceiba; pharmacognosy; thorn extract.

Resumen

Contexto: Bombax ceiba es un árbol de hoja caduca que se encuentra en las regiones tropicales y subtropicales de Asia, África, y Australia. Los sistemas tradicionales de la medicina como Ayurveda, Siddha y Unani han puesto de relieve el uso de las partes de B. ceiba (corteza, hojas y flores) para el tratamiento de numerosas enfermedades como la sensibilidad dolorosa, hepatotoxicidad, hipertensión, infecciones por VIH, fiebre, disentería, inflamación, catarros, úlceras, acné, trastornos ginecológicos, hemorroides y las infecciones urinarias. Sin embargo, no hay estudios científicos farmacognósticos, fitoquímicos y farmacológicos sobre la espina de B. ceiba.

Objetivos: Estudiar las potencialidades farmacognósticas y farmacológicas de extracto de espina de B. ceiba.

Métodos: Las propiedades fisicoquímicas se determinaron mediante pruebas reportadas en la farmacopea. El tamizaje fitoquímico se llevó a cabo utilizando protocolos estándar. La actividad anti- inflamatoria in vitro se realizó mediante el método de estabilización de glóbulos rojos humanos, la actividad antihelmíntica in vitro por el método de Pheretima posthuma, la actividad anti-oxidante in vitro por el método de secuestro de DPPH y los estudios anti-microbianos por el método de dilución en agar contra las bacterias E. coli, B. subtilis, K. neumonía y hongos C. albicans y A. niger.

Resultados: El extracto hidroalcohólico de espina de Bombax ceiba (TEBC) mostró significativa actividad anti- inflamatoria (46.9% de estabilización), vermífuga (muerte en 59.22 min), anti-oxidante (41.62% de inhibición) y anti-microbiana (B. subtilis > E. coli > K. pneumoniaA. niger > C. albicans).

Conclusiones: El studio reveló las características fisicoquímicas, fitoquímicas y farmacognósticas de la espina de B. ceiba. También reveló las potencialidades farmacológicas del extracto.

Palabras Clave: anti-inflamatorio; antimicrobiano; Bombax ceiba; extracto de la espina; farmacognosia; vermífugo.

Download the PDF file .

 

Citation Format: Kamble MA, Mahapatra DK, Dhabarde DM, Ingole A (2017) Pharmacognostic and pharmacological studies of Bombax ceiba thorn extract. J Pharm Pharmacogn Res 5(1): 40-54.
This article has been cited by:
Borikar SP, Kallewar NG, Mahapatra DK, Dumore NG (2018) Dried flower powder combination of Clitoria ternatea and Punica granatum demonstrated analogous anti-hyperglycemic potential as compared with standard drug metformin: In vivo study in Sprague Dawley rats. Journal of Applied Pharmaceutical Science 8(11): 75-79. DOI: 10.7324/JAPS.2018.81111
Joseph TM, Mahapatra DK (2018) Evaluating the antibacterial perspective of cuminaldehyde, a component of Cuminum cyminum against some common human intestinal pathogens. Research & Reviews: Journal of Herbal Science 7(2): 10-12.  Website
Mahapatra DK, Shivhare RS (2018) Anti-microbial perspective of a chalcone, (E)-1-(1- methoxy-9H-carbazol-3-yl)-3-(4-(methylsulfonyl) phenyl)prop-2-en-1-one: Fabrication of a hybrid by unification of a natural product with a synthetic component. Int J Agr Life Sci 4(2): 236-240.DOI: 10.22573/spg.ijals.018.s12200090
Borikar SP, Kallewar NG, Mahapatra DK, Gupta RA, Dumore NG, Danao KR, Mahajan UN (2018) Decoction of Andrographis paniculata whole plant and Gymnema sylvestre leaves demonstrated noteworthy hypoglycemic activity in Sprague Dawley rat. J Phytopharmacol 7(1):84-87. Website
Telrandhe R, Mahapatra DK, Kamble MA (2017) Bombax ceiba thorn extract mediated synthesis of silver nanoparticles: Evaluation of anti-Staphylococcus aureus activity. International Journal of Pharmaceutics & Drug Analysis 5(9): 376–379. Website

© 2017 Journal of Pharmacy & Pharmacognosy Research (JPPRes)

Toxicity evaluation of Ruta angustifolia leaves ethanolic extract
J. Pharm. Pharmacogn. Res., vol. 11, no. 3, pp. 437-447, May-June 2023. DOI: https://doi.org/10.56499/jppres23.1609_11.3.437 Original Article Acute and repeated dose 28-day oral toxicity of Ruta angustifolia Pers. leaves ethanolic extract in Wistar rats [Toxicidad oral aguda y por dosis repetidas durante 28 días del extracto etanólico de hojas de Ruta angustifolia Pers. en ratas Wistar] Tutik … Continue reading Toxicity evaluation of Ruta angustifolia leaves ethanolic extract
Adolescents in Indonesia and COVID-19 pandemic
J. Pharm. Pharmacogn. Res., vol. 11, no. 3, pp. 426-436, May-June 2023. DOI: https://doi.org/10.56499/jppres22.1560_11.3.426 Original Article Perception, mental health, and social media exposure on adolescents in Indonesia during COVID-19 pandemic [Percepción, salud mental y exposición a los medios sociales en adolescentes de Indonesia durante la pandemia de COVID-19] Efa Nugroho1*, Alfiana Ainun Nisa1, Widya Hary Cahyati1, … Continue reading Adolescents in Indonesia and COVID-19 pandemic
Decaffeinated green tea and coffee extracts and metabolic syndrome
J. Pharm. Pharmacogn. Res., vol. 11, no. 3, pp. 414-425, May-June 2023. DOI: https://doi.org/10.56499/jppres23.1593_11.3.414 Original Article Decaffeinated green tea and green coffee extracts as metformin’s add-on enhance metabolic syndrome risk factors and improve the cardiac insulin-gene-related pathway [Extractos de té verde y café verde descafeinados como complemento de la metformina mejoran los factores de riesgo del … Continue reading Decaffeinated green tea and coffee extracts and metabolic syndrome

© 2013-2020 by the authors; licensee JPPRes, Antofagasta, Chile. This journal is an open-access journal distributed under the terms and conditions of the Creative Commons Attribution license-Non Commercial 4.0 international. The content on this site is intended for health professionals. If you are not a health professional, please talk to your doctor about any doubts or concerns regarding your health

Made with ♥ by AVAGAX Studio